Are we using right dose of oxytocin?

Indian Journal of Anaesthesia

Volumn 54, Issue 5, 2010, Pages 371-373

  Devikarani, D ^a   Harsoor, S S ^a  

^a BMC and RI   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CARBOPROST; CYSTYL AMINOPEPTIDASE; ERGOT DERIVATIVE; INFUSION FLUID; MESSENGER RNA; MISOPROSTOL; OXYTOCIN; OXYTOCIN RECEPTOR; PHENYLEPHRINE; PHOSPHOLIPASE C; PROSTAGLANDIN F2; VASOPRESSIN;

BLEEDING; CESAREAN SECTION; CONVULSION; CRYSTALLOID; DOSE RESPONSE; DRUG HALF LIFE; DRUG INDUCED HEADACHE; EDITORIAL; ENZYME ACTIVITY; FIRST TRIMESTER PREGNANCY; FLUSHING; GREAT BLOOD VESSEL; HEART; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART RATE; HORMONE RELEASE; HUMAN; HYPOTENSION; LOADING DRUG DOSE; LOW DRUG DOSE; LUNG EDEMA; MATERNAL MORTALITY; MEAN ARTERIAL PRESSURE; NAUSEA; POSTPARTUM HEMORRHAGE; SIDE EFFECT; ST SEGMENT; SYSTEMIC VASCULAR RESISTANCE; THIRD TRIMESTER PREGNANCY; THORAX PAIN; UTERINE ATONY; UTERINE CERVIX DILATATION; UTERUS CONTRACTION; VOMITING; WATER INTOXICATION;

EID: 79251490739     PISSN: 00195049     EISSN: None     Source Type: Journal    
DOI: 10.4103/0019-5049.71020     Document Type: Editorial

References (24)

1. rd ed. Philadelphia: Elsevier Mosby; 2004. p. 662-82.
2. Prendiville W, Elbourne D, Chalmers I. The effects of routine oxytocic administration in the management of the third stage of labour: an overview of the evidence from controlled trials Br J Obstet Gynaecol 1988;95:3-16.
3. rd ed. New York: McGraw-Hill Medical; 2010. p. 374-409.
4. Marcus HE, Fabian A, Lier H, Dagtekin O, Böttiger BW, Teschendorf P, et al. Survey on the use of oxytocin for cesarean section. Minerva Anestesiol 2010 [In Press].
5. Gutkowska J, Jankowski M, Mukaddam-Daher S, McCann SM. Oxytocin is a cardiovascular hormone. Braz J Med Biol Res 2000;33:625-33.
6. Shojo H, Kaneko Y. Characterization and expression of oxytocin and the oxytocin receptors. Mol Genet Metab 2001;71:552-8.
7. rd ed. Philadelphia: Lippincot-Raven Publishers; 1999. p. 409-26.
8. Blanks AM, Shmygol A, Thornton S. Regulation of oxytocin receptors and oxytocin receptor signaling. Semin Reprod Med 2007;25:52-9.
9. Fuchs AR, Fuchs F, Husslein P, Soloff MS. Oxytocin receptors in the human uterus during pregnancy and parturition. Am J Obstet Gynecol 1984;150:734-41.
10. Kimura T, Takemura M, Nomura S, Nobunaga T, Kubota Y, Inoue T, et al. Expression of oxytocin receptor in human pregnant myometrium. Endocrinology 1996;137:780-5.
11. Carvalho JC, Balki M, Kingdom J, Windrim R. Oxytocin requirements at elective cesarean delivery: a dose-finding study. Obstet Gynecol 2004;104:1005-10.
12. Balki M, Ronayne M, Davies S, Fallah S, Kingdom J, Windrim R, et al. Minimum oxytocin dose requirement after cesarean delivery for labour arrest. Obstet Gynecol 2006;107:45-50.
13. George RB, McKeen D, Chaplin AC, McLeod L. Up-down determination of the ED(90) of oxytocin infusions for the prevention of postpartum uterine atony in parturients undergoing. Can J Anaesth 2010;57:578-82.
14. Sarna MC, Soni AK, Gomez M, Oriol NE. Intravenous oxytocin in patient undergoing elective cesarean section. Anesth Analg 1997;84:753-6.
15. Butwick AJ, Coleman L, Cohen SE, Riley ET, Carvalho B. Minimum effective bolus dose of oxytocin during elective caesarean delivery. Br J Anaesth 2010;104:338-43.
16. Robinson C, Schumann R, Zhang P, Young RC. Oxytocininduced desensitization of the oxytocin receptor. Am J Obstet Gynecol 2003;188:497-502.
17. Pinder AJ, Dresner M, Calow C, Shorten GD, O'Riordan J, Johnson R. Haemodynamic changes caused by oxytocin during caesarean section under spinal anaesthesia. Int J Obstet anaesth 2002;11:156-9.
18. Thomas JS, Koh SH, Cooper GM. Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing Caesarean section. Br J Anaesth 2007;98:116-9.
19. Weis FR Jr, Markello R, Mo B, Bochiechio P. Cardiovascular effects of oxytocin. Obstet Gynecol 1975;46:211-4.
20. Archer TL, Knape K, Liles D, Wheeler AS, Carter B. The hemodynamics of oxytocin and other vasoactive agents during neuraxial anesthesia for cesarean delivery: findings in six cases. Int J Obstet Anesth 2008;17:247-54.
21. Hendricks CH, Brenner WE. Cardiovascular effects of oxytocic drugs used postpartum. Am J Obstet Gynecol 1970;108: 751-60.
22. Svanström MC, Biber B, Hanes M, Johansson G, Näslund U, Bålfors EM. Signs of myocardial ischaemia after injection of oxytocin: a randomized double-blind comparison of oxytocin and methylergometrine during Caesarean section. Br J Anaesth 2008;100:683-9.
23. Vercauteren M, Palit S, Soetens F, Jacquemyn Y, Alahuhta S. Anaesthesiological considerations on tocolytic and uterotonic therapy in obstetrics. Acta Anaesthesiol Scand 2009;53:701-9.
24. Dyer RA, Reed AR, van Dyk D, Arcache MJ, Hodges O, Lombard CJ, et al. Hemodynamic effects of ephedrine, phenylephrine, and the coadministration of phenylephrine with oxytocin during spinal anesthesia for elective cesarean delivery. Anesthesiology 2009;111:753-76.